Is a shock‑absorbing garment used in the management of elevated intracranial pressure (ICP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, shock-absorbing garments (MAST/pneumatic antishock trousers) are not used in the management of elevated intracranial pressure (ICP).

Shock garments are contraindicated in modern ICP management and have no role in current neurocritical care protocols. While historical research from 1981 examined pneumatic antishock trousers (MAST) in the context of head injury, this intervention is not part of contemporary ICP management strategies outlined in current guidelines 1, 2.

Current Evidence-Based ICP Management

The management of elevated ICP follows structured, protocol-driven approaches that focus on:

Core Monitoring Strategies

  • ICP and cerebral perfusion pressure (CPP) monitoring are fundamental to caring for patients with acute brain injury, particularly those in coma 2
  • Both parenchymal ICP monitors and external ventricular drains (EVD) provide reliable data and are the recommended devices 2
  • ICP monitoring should be used to guide medical and surgical interventions, with treatment thresholds generally considered to be greater than 20-25 mmHg 2

Decision-Making Framework

The decision to monitor ICP is primarily determined by 1:

  • Consciousness examination (Glasgow Coma Scale)
  • Suspicion that ICP is elevated
  • Concern for neuroworsening without quantitative ICP data
  • Value in guiding resuscitation and calculating CPP
  • Early warning system for potential deterioration

Modern Management Components 3

  • Mechanical ventilation optimization
  • Fluid therapy management
  • Hemoglobin target adjustment
  • Hypertonic saline infusion
  • Advanced bedside neuromonitoring

Historical Context on Shock Garments

The 1981 canine study 4 examined MAST devices and found that while ICP did increase with inflation, cerebral perfusion pressure (MAP-ICP) improved in hypovolemic animals. However, this outdated research has no relevance to current ICP management protocols and should not inform modern practice.

Current guidelines make no mention of shock garments as a therapeutic intervention for ICP management, focusing instead on invasive monitoring, medical therapies, and surgical interventions when indicated 1, 2, 3.

Related Questions

Do we administer antihypertensives to patients with hypertension and elevated intracranial pressure (ICP)?
What are the normal intracranial pressure (ICP) values, treatment thresholds, and recommended management steps?
How should cerebrospinal fluid physiology be maintained during neuroanesthesia, including optimal intracranial pressure range, anesthetic agents, ventilation targets, and interventions for elevated ICP?
What are the normal values for cerebrospinal fluid (CSF) pressure, intracranial pressure (ICP), cerebral perfusion pressure (CPP), and other key parameters of cerebral physiology?
What is an intraparenchymal intracranial pressure (ICP) sensor, its uses, indications, and how to interpret its readings?
Which non‑sedating second‑generation H1 antihistamines are recommended for allergic symptoms, and what are the appropriate doses for adults, children (2‑5, 6‑11, ≥12 years), pregnant or breastfeeding patients, and the elderly with contraindications to first‑generation agents?
What are the indications, recommended adult dosing, and contraindications for using sedating antihistamines?
What is the maximum total daily dose of Focalin XR (dexmethylphenidate) for pediatric patients (≥6 years) and for adults?
What is the pathophysiology of gastroesophageal reflux disease?
In a reproductive‑age woman with amenorrhea, what do a prolactin level of 20.8 ng/mL and a progesterone level of 0.6 ng/mL indicate?
What non‑laxative measures can be used to relieve constipation in a toddler?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.